Last reviewed · How we verify
HEC 68498
At a glance
| Generic name | HEC 68498 |
|---|---|
| Sponsor | Sunshine Lake Pharma Co., Ltd. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Clinical Study of HEC68498 in Patients With Advanced Refractory Solid Tumors (PHASE1)
- The Safety, Tolerability and Pharmacokinetic Study of HEC68498 in Healthy Male and Female Subjects (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |